In this study, we systematically investigated the role of Sesn2 in myocardial hypertrophy; the results showed that Sesn2 inhibits myocardial hypertrophy by inhibiting the mTORC1 pathway, thereby regulating protein synthesis, metabolism, autophagy, and apoptosis. Here, SESN2 is linked to cardiac hypertrophy.